Trimediazine 15% Premix for medicated feeding stuff

Country: Irlanda

Lingwa: Ingliż

Sors: HPRA (Health Products Regulatory Authority)

Ixtrih issa

Ingredjent attiv:

Sulfadiazine, Trimethoprim

Disponibbli minn:

Vetoquinol UK Limited

Kodiċi ATC:

QJ01EW10

INN (Isem Internazzjonali):

Sulfadiazine, Trimethoprim

Dożaġġ:

12.5/2.5 percent weight/weight

Għamla farmaċewtika:

Premix for medicated feeding stuff

Tip ta 'preskrizzjoni:

POM: Prescription Only Medicine as defined in relevant national legislation

Grupp terapewtiku:

Chickens, Pigs, Turkeys

Żona terapewtika:

sulfadiazine and trimethoprim

Indikazzjonijiet terapewtiċi:

Antibacterial

L-istatus ta 'awtorizzazzjoni:

Authorised

Data ta 'l-awtorizzazzjoni:

1988-10-01

Karatteristiċi tal-prodott

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Trimediazine 15% Premix for medicated feeding stuff
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Premix for medicated feeding stuff.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Chickens, turkeys and pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Trimediazine 15% Premix is indicated for use in the treatment of
diseases caused by bacteria sensitive to potentiated
sulphonamides.
Chickens and turkeys:
For use in the treatment of diseases caused by bacteria sensitive to
potentiated sulphonamides
including infections due to_ Salmonella_ infection and pasteurellosis.
Pigs: For the treatment of atrophic rhinitis when associated with_
Bordetella bronchiseptica_ and streptococcal meningitis
caused by_ Streptococcus suis_ type II.
4.3 CONTRAINDICATIONS
The product should not be administered to animals with known
sulphonamide hypersensitivity.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Not applicable.
Sulfadiazine
12.5% w/w
Trimethoprim
2.5% w/w
Limestone Flour
to 100.0%
For a full list of excipients, see section 6.1
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_4_
_/_
_1_
_2_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_5_
_4_
_4_
_3_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
To avoid possible crystalluria, adequate water intake is essential.
Particular care is needed with animals suff
                                
                                Aqra d-dokument sħiħ
                                
                            

Fittex twissijiet relatati ma 'dan il-prodott